Centre Léon Bérard in France has inaugurated the first NaviFUS system in Europe, advancing focused ultrasound research for blood-brain barrier opening and brain metastases.
The 2026 FUS-PULSE white paper highlights 11 NaviFUS procedures reported in the RNI clinical program, safety findings, image-guided navigation, and NaviFUS’ contribution to technical discussions on focused ultrasound neuromodulation.
PBS’ Resolve to Solve highlights WVU Rockefeller Neuroscience Institute’s focused ultrasound research for addiction and a broader challenge for the field: making non-invasive brain therapy more practical, accessible, and scalable.
The Focused Ultrasound Foundation featured NaviFUS’ recent Epilepsia publication on non-invasive focused ultrasound neuromodulation for drug-resistant epilepsy, highlighting the study’s clinical significance and continued development of the field.
Focused ultrasound is opening new possibilities for how we reach and interact with the brain — without traditional surgery.
In a recent feature, WIRED explored the work of Dr. Ali Rezai and the WVU Rockefeller Neuroscience Institute (RNI), highlighting the evolving role of focused ultrasound in neurological and behavioral research.
NaviFUS Corporation announced the online publication of “Low-intensity focused ultrasound neuromodulation for drug-resistant epilepsy: A randomized, sham-controlled crossover trial.” Conducted at Taipei Veterans General Hospital, the pilot, single-blind study enrolled 12 adults with drug-resistant epilepsy. Each participant completed both low-intensity focused ultrasound (LIFU) and sham treatment, allowing the study to evaluate individualized targeting, preliminary safety, clinical feasibility, and efficacy signals.
Children’s National Hospital is advancing new possibilities in pediatric brain tumor care through expanded focused ultrasound research using the NaviFUS neuronavigation-guided low-intensity focused ultrasound (LIFU) platform. The collaboration supports ongoing efforts to explore non-invasive therapeutic approaches for children with difficult-to-treat brain tumors.
Key Points：
-Researchers in Taiwan completed an early-stage trial showing focused ultrasound–mediated blood-brain barrier opening plus chemotherapy is safe in patients with GBM.
– The investigators are now recruiting participants for a larger clinical trial with the same device – the NaviFUS system – at two sites.
